Spectral ai announces confirmation of compliance of its nasdaq listing requirements

Dallas, dec. 23, 2024 (globe newswire) -- spectral ai (nasdaq: mdai) (“spectral ai” or the “company”), developer of the ai-driven deepview® system, which received breakthrough device designation from the u.s. fda in 2018, that uses multi-spectral imaging and algorithms to predict burn healing potential, is pleased to announce that on december 20, 2024 the company received a “moot” letter from nasdaq confirming that the company has regained compliance with all applicable listing standards for its continued listing on the nasdaq capital market and that a further hearing regarding the company's compliance is no longer necessary.
NDAQ Ratings Summary
NDAQ Quant Ranking